DiaMedica Receives FDA Feedback on DM199 Preeclampsia Nonclinical Program
FREE Breaking News Alerts from StreetInsider.com!
StreetInsider.com Top Tickers, 10/28/2026
- Wall Street ends higher as Fed holds key rate steady, focus turns to earnings
- SK Hynix shares surge after Q3 profit beats expectations
- Oil prices rise on Yemen fighting, Saudi refinery attack
- Alphabet stock rises as OpenAI plans to buy Google's TPUs
- Wendy's shares surge 16% on $1.4 billion takeover bid by Nelson Peltz’s Trian Fund
| (NASDAQ: DMAC) | Delayed: 9.82 +1.13 (13.00%) | |||||
|---|---|---|---|---|---|---|
| Previous Close | $8.69 | 52 Week High | $ | |||
| Open | $8.71 | 52 Week Low | $ | |||
| Day High | $10.13 | P/E | N/A | |||
| Day Low | $8.60 | EPS | $ | |||
| Volume | 521,282 | |||||
